 an ofﬁce-administered 6minute walk performance test exhibited signiﬁcantly increased
mortality (odds ratio [OR], 2.36).
4A. Pharmacotherapy for patients with claudication:
Risk reduction
Patients with IC carry a signiﬁcant systemic burden of
atherosclerosis and are at risk for its associated complications.
These patients should have lifelong treatment designed to
eliminate or modify known risk factors for atherosclerosis to
reduce the